RE:Datametrex - 12 months and $60 million rev laterAiking wrote: Datametrex in 2021:
- Covid testing for Air travellers
- Aquistion of Concierge Medical
- Testing for Air Canada
- Expands LOTTE prefered vendor agreement
- OTCQB listing
- COVID19 rapid antigen test authorization by Health Canada
- sold tests to the largest streaming company in the world
- reported $12,3 million revenue in 2020 (264% up from 2019)
- AI contracts LOTTE
- AI contract with Incheon International Airport
- AI contracts with Shinhan Financial Group (project JobMInd)
- Aquisition of Medi-Call
- Signed testing contracts for four new shows thourgh mid-2022
- Bid on $40 million Ai contract and got selected to the final round
- Signed testing contract with major worldwide media & entertainment company
- launches Medi-Call smartphone app beta test
- Ai contract with Samsung
- Ai contract for EV charging platform
- sale fo Concierge Medical
- secures rights to distribute portable COVID Lamp PCR test
DM trades at the same price like 12 months ago, this is not rational, it's definitely manipulation by big players. To me it's a clear buy and hold for longterm growth!
All good reasons to buy. I said it before and I''l say it again, the institutions are very good at collecting their shares at the prices they want. Just go with the flow. I'll patiently wait to see how far they want to take this stock down. It's not often you see a stock have 14 straight days that are either down or even. The stock have been in the oversold for a few days now. The manipulation is pretty obvious. Most of the volume continues to occur on the ATS away from the eyes of the majority of the retail investors. Today the venture traded 796 500 shares where as the ATS traded about 1.2 million shares. All last week the ATS traded around twice to three times the amount of shares on the Venture.